0000874015-23-000228.txt : 20231218
0000874015-23-000228.hdr.sgml : 20231218
20231218165604
ACCESSION NUMBER: 0000874015-23-000228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monia Brett P
CENTRAL INDEX KEY: 0001537529
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 231494501
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
STREET 2: C/O IONIS PHARMACEUTICALS, INC.
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-12-14
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001537529
Monia Brett P
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
1
0
0
Chief Executive Officer
1
Common Stock
2023-12-14
4
M
0
14860
47.34
A
132971
D
Common Stock
2023-12-14
4
S
0
14860
49.2133
D
118111
D
Common Stock
2023-12-14
4
M
0
9140
47.34
A
127251
D
Common Stock
2023-12-14
4
S
0
9140
50.187
D
118111
D
Non-Qualified Stock Option (right to buy)
47.34
2023-12-14
4
M
0
14860
0.0
D
2018-01-03
2024-01-02
Common Stock
14860
33140
D
Non-Qualified Stock Option (right to buy)
47.34
2023-12-14
4
M
0
9140
0.0
D
2018-01-03
2024-01-02
Common Stock
9140
24000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.75 to $49.75 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.50 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
By: Patrick R. O'Neil, attorney-in-fact For: Brett P. Monia
2023-12-15